Neurocrine Biosciences reported $100K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Abbvie ABBV:US $ 18M 0M
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Acorda Therapeutics ACOR:US $ 0.01M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31247M 849M
Aptinyx Inc APTX:US $ 677K 0
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Cytokinetics CYTK:US $ 0.08M 0M
Dynavax Technologies DVAX:US $ 0.13M 0M
Enanta Pharmaceuticals ENTA:US $ 0.21M 0M
Exelixis EXEL:US $ 0.32M 0M
Gilead Sciences GILD:US $ 1M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Prothena PRTA:US $ 0.47M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Repligen RGEN:US $ 0.55M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Teva Pharmaceutical TEVA:IT 57M 0
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0.1M
Xoma XOMA:US $ 86K 1000
YTE INCY:US $ 0.22M 0M